DiaSorin
Diasorin Non-COVID Revenues Jump 8 Percent on Rising Immunodiagnostics, Molecular Testing Business
The firm reported gains in immunodiagnostics and molecular testing revenues in Europe and North America during the first half of 2024, offset by declines elsewhere.
Diasorin Nabs FDA De Novo Clearance for Candida Auris Assay
The firm said that the test can be used to help prevent and control the spread of the fungal pathogen, which is a common cause of hospital-acquired infections.
FDA Grants 510(k) Clearances to BioMérieux, Roche, Philips, Diasorin, Others in June
Antimicrobial susceptibility tests, digital pathology slide creation and analysis systems, and a molecular fungemia panel were among the products cleared in June.
Top Five Articles on 360Dx Last Week: Children's Hospitals and FDA's Final LDT Rule; More
Last week, readers were most interested in a story about the effect that children's hospitals expect from the FDA's final rule on LDTs.
Diasorin Nabs 510(k) Clearance for Fungemia Panel
The Liaison Plex Yeast Blood Culture Assay is used for the detection of 16 pathogens that are commonly associated with fungal bloodstream infections.